RAC - Charts & Price Action, page-8953

I can't disagree with this. This point has bugged me, but you could question his reasons for selling til the cows come home. Some would sell to derisk (he is heavily invested), maybe he disagrees with the new pathway race has taken? Possibly he doesn't believe the m6a pathway is relevant.

we won't know this answer, but instead of being an elephant in the room, all we as holders can continue to do is research. From a contrarian viewpoint, we have had 2 other scientists join the team. Does that mean if we just take that type of info in isolation, then we're on a sure thing? Of course not.

ultimately, despite the great preclinical, it is still preclinical. ASX investors are cagey and risk adverse with their money. I'm not sure how much research one has gone into, as the whole m6a pathway is very complex to understand.

I guess another question is whether you believe the historical results are relevant to the new(found) mechanism that applies to Zantrene, and how relevant this new mechanism is for treatment of cancer. Investors here do, but clearly, this doesn't appear to be believed by the market. I am in complete agreement with you, there are no buyers at this point in time.